Is BIIB or IDXX cheaper?

On trailing earnings, BIIB is cheaper: BIIB trades at a 21.42 P/E and IDXX at 41.36.

Which has grown faster, BIIB or IDXX?

Over the past five years, IDXX grew revenue faster — BIIB at a -4.80% CAGR versus IDXX at 9.24%.

Is BIIB or IDXX more profitable?

IDXX runs the higher net margin — BIIB at 13.92% versus IDXX at 24.63%.

Which has been the better investment, BIIB or IDXX?

Over the past 10-year, IDXX delivered the higher annualized total return — BIIB at -2.05% versus IDXX at 20.22%. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs IDEXX Laboratories, Inc. (IDXX)

IDXX leads on 8 of 15 compared metrics, though BIIB is the cheaper stock.

A side-by-side comparison of Biogen Inc. and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

IDEXX Laboratories, Inc.

$44.24B

$560.88Healthcare

Total return — BIIB vs IDXX

growth of $100 · last 30y

BIIB +4725.3%IDXX +10042.5%IDXX compounded faster

BIIB IDXX

BIIB vs IDXX: by the numbers

•IDXX is the larger company ($44.24B vs $29.53B market cap).
•BIIB trades at the lower earnings multiple (21.42 vs 41.36 P/E).
•IDXX converts more revenue to profit (24.63% vs 13.92% net margin).
•IDXX grew revenue faster over the past five years (9.24% vs -4.80% CAGR).

Which is better, BIIB or IDXX?

Metric tally: BIIB 7 · IDXX 8

It depends on what you're optimizing for:

ValueBIIB(lower P/E)

GrowthIDXX(faster 5Y revenue CAGR)

QualityIDXX(higher ROIC)

Valuation

Metric	BIIB	IDXX
P/E ratio	21.42●	41.36
Forward P/E	12.23●	33.85
P/S ratio	3.01●	10.18
P/B ratio	1.59●	29.08
PEG ratio	—	2.30
EV / EBITDA	12.16●	29.61
FCF yield	8.83%●	2.39%

Profitability

Metric	BIIB	IDXX
Gross margin	69.77%●	62.05%
Operating margin	15.65%	31.63%●
Net margin	13.92%	24.63%●
ROE	7.36%	70.38%●
ROIC	6.62%	40.27%●

Growth (annualized)

Metric	BIIB	IDXX
Revenue CAGR (5Y)	-4.80%	9.24%●
EPS CAGR (5Y)	-18.67%	14.07%●
FCF CAGR (5Y)	-3.59%	10.13%●
Total return CAGR (5Y)	-12.79%	-0.82%●

Frequently asked

Which is better, BIIB or IDXX?: It depends on your goal. value: BIIB (lower P/E); growth: IDXX (faster 5Y revenue CAGR); quality: IDXX (higher ROIC). Across all compared metrics, IDXX leads 8 to 7.
Is BIIB or IDXX cheaper?: On trailing earnings, BIIB is cheaper: BIIB trades at a 21.42 P/E and IDXX at 41.36.
Which has grown faster, BIIB or IDXX?: Over the past five years, IDXX grew revenue faster — BIIB at a -4.80% CAGR versus IDXX at 9.24%.
Is BIIB or IDXX more profitable?: IDXX runs the higher net margin — BIIB at 13.92% versus IDXX at 24.63%.
Which has been the better investment, BIIB or IDXX?: Over the past 10-year, IDXX delivered the higher annualized total return — BIIB at -2.05% versus IDXX at 20.22%. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full IDXX analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio IDEXX Laboratories P/E ratio Biogen dividend yield IDEXX Laboratories dividend yield Biogen ROE IDEXX Laboratories ROE Biogen operating margin IDEXX Laboratories operating margin Biogen revenue growth IDEXX Laboratories revenue growth Biogen free cash flow IDEXX Laboratories free cash flow

Biogen & IDEXX Laboratories appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.